Cuenca Jimena, Le-Gatt Alice, Castillo Valentina, Belletti Jose, Díaz Macarena, Kurte G Mónica, Gonzalez Paz L, Alcayaga-Miranda Francisca, Schuh Christina M A P, Ezquer Fernando, Ezquer Marcelo, Khoury Maroun
Consorcio Regenero, Chilean Consortium for Regenerative Medicine, Santiago, Chile.
Laboratory of Nano-Regenerative Medicine, Faculty of Medicine, Universidad de los Andes, Santiago, Chile.
Front Physiol. 2018 May 14;9:464. doi: 10.3389/fphys.2018.00464. eCollection 2018.
Considerable advances have been made toward understanding the cellular and molecular mechanism of wound healing, however, treatments for chronic wounds remain elusive. Emerging concepts utilizing mesenchymal stem cells (MSCs) from umbilical cord, adipose tissue and bone marrow have shown therapeutical advantages for wound healing. Based on this positive outcome, efforts to determine the optimal sources for MSCs are required in order to improve their migratory, angiogenic, immunomodulatory, and reparative abilities. An alternative source suitable for repetitive, non-invasive collection of MSCs is from the menstrual fluid (MenSCs), displaying a major practical advantage over other sources. This study aims to compare the biological functions and the transcriptomic pattern of MenSCs with umbilical cord MSCs in conditions resembling the wound microenvironment. Consequently, we correlate the specific gene expression signature from MenSCs with changes of the wound matrix signals . The direct comparison revealed a superior clonogenic and migratory potential of MenSCs as well as a beneficial effect of their secretome on human dermal fibroblast migration . Furthermore, MenSCs showed increased immunomodulatory properties, inhibiting T-cell proliferation in co-culture. We further, investigated the expression of selected genes involved in wound repair (growth factors, cytokines, chemokines, AMPs, MMPs) and found considerably higher expression levels in MenSCs (ANGPT1 1.5-fold; PDGFA 1.8-fold; PDGFB 791-fold; MMP3 21.6-fold; ELN 13.4-fold; and MMP10 9.2-fold). This difference became more pronounced under a pro-inflammatory stimulation, resembling wound bed conditions. Locally applied in a murine excisional wound splinting model, MenSCs showed a significantly improved wound closure after 14 days, as well as enhanced neovascularization, compared to the untreated group. Interestingly, analysis of excised wound tissue revealed a significantly higher expression of VEGF (1.42-fold) among other factors, translating an important conversion of the matrix signals in the wound site. Furthermore, histological analysis of the wound tissue from MenSCs-treated group displayed a more mature robust vascular network and a genuinely higher collagen content confirming the pro-angiogenic and reparative effect of MenSCs treatment. In conclusion, the superior clonogenicity, immunosuppressive and migration potential in combination with specific paracrine signature of MenSCs, resulted in an enhanced wound healing and cutaneous regeneration process.
在理解伤口愈合的细胞和分子机制方面已经取得了相当大的进展,然而,慢性伤口的治疗方法仍然难以捉摸。利用来自脐带、脂肪组织和骨髓的间充质干细胞(MSCs)的新兴概念已显示出在伤口愈合方面的治疗优势。基于这一积极成果,需要努力确定MSCs的最佳来源,以提高其迁移、血管生成、免疫调节和修复能力。一种适合重复、非侵入性采集MSCs的替代来源是月经血(MenSCs),与其他来源相比具有主要的实际优势。本研究旨在比较MenSCs与脐带MSCs在类似伤口微环境条件下的生物学功能和转录组模式。因此,我们将MenSCs的特定基因表达特征与伤口基质信号的变化相关联。直接比较显示MenSCs具有更高的克隆形成和迁移潜力,以及其分泌组对人真皮成纤维细胞迁移的有益作用。此外,MenSCs表现出增强的免疫调节特性,在共培养中抑制T细胞增殖。我们进一步研究了参与伤口修复的选定基因(生长因子、细胞因子、趋化因子、抗菌肽、基质金属蛋白酶)的表达,发现MenSCs中的表达水平显著更高(血管生成素1 1.5倍;血小板衍生生长因子A 1.8倍;血小板衍生生长因子B 791倍;基质金属蛋白酶3 21.6倍;弹性蛋白13.4倍;基质金属蛋白酶10 9.2倍)。在促炎刺激下,这种差异变得更加明显,类似于伤口床条件。在小鼠切除伤口夹板模型中局部应用MenSCs,与未治疗组相比,14天后伤口闭合明显改善,血管生成增强。有趣的是,对切除的伤口组织的分析显示,在其他因素中,血管内皮生长因子(VEGF)的表达显著更高(1.42倍),这转化了伤口部位基质信号的重要转变。此外,对MenSCs治疗组伤口组织的组织学分析显示,血管网络更成熟、更强大,胶原蛋白含量确实更高,证实了MenSCs治疗的促血管生成和修复作用。总之,MenSCs优越的克隆形成能力、免疫抑制和迁移潜力,以及特定的旁分泌特征,导致伤口愈合和皮肤再生过程增强。